Abstract:Electronic health records can be used to track diagnoses and drug prescriptions in large heterogeneous populations over time. Coupled with recent advances in causal inference from observational data, these records offer new opportunities to emulate clinical trials and identify potential targets for drug repositioning. Here, we run a hypothesis generating cohort study of Danes aged 50 to 80 years from 2001 to 2015 (n = 2,512,380), covering a total of 23,371,354 years of observations. We examine prescription drugs at ATC level-4 and their effect on 9 major disease outcomes. Using Bayesian time-varying Cox regression and longitudinal minimum loss estimation, our analysis successfully reproduces known drug-disease associations from clinical trials, such as the reduction in the 3-year absolute risk of death associated with Statins (ATC:C10AA) -0.8% (95% CI =[-1.2%, -0.5%]) and -0.8% (95% CI =[-1.3%, -0.2%]) for females and males, respectively. Additionally, we discovered novel associations that suggest potential repositioning opportunities. For instance, Statins were associated with a reduction in the 3-year absolute risk of dementia by -0.3% (95% CI =[-0.5%, -0.1%]) for females and -0.2% (95% CI =[-0.4%, 0.1%]) for males. Furthermore, Biguanides (ATC:P01BB) stands out as a particularly interesting candidate with absolute risk reductions across various outcomes. In total, we identified 76 potential drug-disease pairs for further investigation. However, it should be stressed that the emulation of clinical trials here is solely of hypothesis generating nature and identified effects need to be corroborated with additional evidence, preferably from RTCs, as the risk of confounding by indication in this study is substantial. In summary, this study provides a large-scale screen of prescribed drugs and their effect on major debilitating disease in the Danish health registries. This provides an additional source of information that can be used in the search for possible repositioning candidates.

Application of Targeted Maximum Likelihood Estimation in Active Drug Safety Surveillance

Causal Evaluation of Post-Marketing Drugs for Drug-induced Liver Injury from Electronic Health Records*

Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies

Targeted Maximum Likelihood Estimation of Community-based Causal Effect of Community-Level Stochastic Interventions

A new approach to hierarchical data analysis: Targeted maximum likelihood estimation for the causal effect of a cluster-level exposure

Targeted learning in observational studies with multi‐valued treatments: An evaluation of antipsychotic drug treatment safety

Targeted learning in observational studies with multi-valued treatments: An evaluation of antipsychotic drug treatment safety

One-step Targeted Maximum Likelihood for Time-to-event Outcomes

Handling missing data when estimating causal effects with Targeted Maximum Likelihood Estimation

Bayesian Dose Finding by Jointly Modelling Toxicity and Efficacy As Time-To-Event Outcomes

Targeted Maximum Likelihood Estimation using Exponential Families

Adaptive designs for identifying optimal biological dose for molecularly targeted agents.

A Bayesian Quasi-Likelihood Design for Identifying the Minimum Effective Dose and Maximum Utility Dose in Dose-Ranging Studies

Doubly Robust Targeted Estimation of Conditional Average Treatment Effects for Time-to-event Outcomes with Competing Risks

Machine Learning in Causal Inference: Application in Pharmacovigilance

Establishment of a Rapid Identification of Adverse Drug Reaction Program in R Language Implementation Based on Monitoring Data

Lip adaptation to simulated dental arch expansion. Part 1: Reliability and precision of two lip pressure measurement mechanisms.

Using Longitudinal Targeted Maximum Likelihood Estimation in Complex Settings with Dynamic Interventions

Targeted-BEHRT: Deep learning for observational causal inference on longitudinal electronic health records

Targeted inference to identify drug repositioning candidates in the Danish health registries

Online causal inference with application to near real‐time post‐market vaccine safety surveillance